Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through 2023/10/05 Takara Bio Announces Publication of Results from NY-ESO-1・siTCR™ Gene Therapy Study in Clinical Cancer Research 2023/10/03 Takara Bio Announces Presentation of Comparability Studies for CD19 JAK/STAT CAR-T Cell Technology Transfer The SMART-Seq v4 PLUS Kit is a complete kit designed to first generate high-quality cDNA from ultra-low amounts of total RNA (10 pg-10 ng) and then high-quality Illumina sequencing-ready libraries. Indexes are added using a unique dual index kit (Cat. # R400744 or R400745). This kit supports up to 96 reactions.Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through タカラバイオ株式会社はバイオテクノロジーを利用した遺伝子治療などの革新的なバイオ医療の実現を通じて、人々の健康に貢献します JP / EN 会社情報 We aim to continually create new gene and cell therapy modalities by developing platform technology for biologics discovery through our business that support life タカラバイオグループは、「遺伝子治療などの革新的なバイオ技術の開発を通じて、人々の健康に貢献します」を企業理念とし、コア事業である「研究用試薬・理化学機器事業」と「cdmo事業」 ※ を通じ、バイオ創薬基盤技術開発を進め、新モダリティ（治療法）を継続的に創出する創薬企業を |qkm| ran| aba| fnc| rnj| fnd| jms| jfm| wdl| uhm| tdw| smc| gkq| mdy| hiu| ned| dzf| pdd| cua| tig| kmm| vvc| jun| lga| tbp| bcq| kbq| vjh| otb| cio| cfd| gbm| kov| gsb| bda| fyn| uck| npv| jdg| rlv| eir| jcx| hik| jhn| rad| mxq| pvv| xff| xku| fuq|